OXFORD DRUG DESIGN
InhibOx is a pioneer in the development and application of new technologies to drive drug discovery. Their multidisciplinary research team has brought together breakthroughs in computational chemistry, cheminformatics, mathematics, cloud computing and software-as-a-service (SaaS) delivery methods to create DrugFinder: the next generation drug discovery platform.
OXFORD DRUG DESIGN
Industry:
Biotechnology Delivery SaaS Software
Founded:
2001-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oxforddrugdesign.com
Total Employee:
1+
Status:
Active
Contact:
441865261471
Email Addresses:
[email protected]
Total Funding:
11.26 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Inova.io
Inova is the leading provider of digital partnering solutions for the biopharma industry.
K1 Investment Management
K1 is a Los Angeles-based private equity firm investing primarily in software and technology private companies across North America.
Current Employees Featured
Founder
Investors List
O2h Ventures
O2h Ventures investment in Convertible Note - Oxford Drug Design
ACF Investors
ACF Investors investment in Convertible Note - Oxford Drug Design
R42 Group
R42 Group investment in Convertible Note - Oxford Drug Design
Meltwind Advisory
Meltwind Advisory investment in Convertible Note - Oxford Drug Design
ACF Investors
ACF Investors investment in Venture Round - Oxford Drug Design
O2h Ventures
O2h Ventures investment in Venture Round - Oxford Drug Design
Department of Health and Social Care (DHSC)
Department of Health and Social Care (DHSC) investment in Grant - Oxford Drug Design
CARB-X
CARB-X investment in Grant - Oxford Drug Design
Top Technology Ventures
Top Technology Ventures investment in Venture Round - Oxford Drug Design
Official Site Inspections
http://www.oxforddrugdesign.com Semrush global rank: 8.19 M Semrush visits lastest month: 354
- Host name: sh-cp2-uk.yyz2.servername.online
- IP address: 66.102.133.221
- Location: Hawthorne United States
- Latitude: 33.9168
- Longitude: -118.3432
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90250
More informations about "Oxford Drug Design"
Home - Oxford Drug Design
Oxford Drug Design Ltd Oxford Centre for Innovation New Road Oxford OX1 1BY, UK. [email protected] +44 (0)1865 261468See details»
Oxford Drug Design - Crunchbase Company Profile
Organization. Oxford Drug Design . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 441865261471; …See details»
Who we are - Oxford Drug Design
Our expert team is drawn from leading specialists in the pharmaceutical and biomedical industries. We bring a unique blend of expertise in medicinal and computational therapeutics alongside a trackrecord in emerging innovation …See details»
Overview - Oxford Drug Design
At Oxford Drug Design we leverage our knowledge of tRNA synthetases (aaRS) and generative AI methods to rapidly advance multiple drug candidates to the clinic – promising new therapies …See details»
Oxford Drug Design - Org Chart, Teams, Culture
View Oxford Drug Design's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Oxford Drug Design Overview | SignalHire Company Profile
Organization Website: oxforddrugdesign.com : Oxford Drug Design industries Biotech: Headquarters Location: Oxford Centre for Innovation, OX1 1BY GB Oxford Centre for …See details»
Oxford Drug Design | LinkedIn
Oxford Drug Design, an advanced spinout from Oxford University, is an innovative biotechnology company discovering and developing novel therapeutics supported by pioneering …See details»
Oxford Drug Design - VentureRadar
"Oxford Drug Design is an innovative company spun-out of Professor Graham Richards' group at the University of Oxford. The company has developed fast, state-of-the-art virtual screening …See details»
Oxford Drug Design - Company Profile - Tracxn
Oct 22, 2024 Oxford Drug Design - Provider of computer-aided design of antibiotics for MDR infections. Raised a total funding of $12.4M over 7 rounds from 12 investors. Founded by …See details»
Oxford Drug Design - PitchBook
Dec 19, 2019 Oxford Drug Design General Information Description. Operator of a biotechnology company intended to develop therapies to treat drug-resistant infections. The company's …See details»
Oxford Drug Design - VentureRadar
Oxford Drug Design is an innovative company spun-out of Professor Graham Richards' group at the University of Oxford. The company has developed fast,... ... Find out ...See details»
Oxford Drug Design - Overview, News & Similar companies
Oxford Drug Design. Business Services · United Kingdom · <25 Employees. Oxford Drug Design is based in Oxford, UK. Founded in 2001 as a spin-out company from the Oxford University …See details»
Platform - Oxford Drug Design
AI and machine learning are transforming drug discovery. Oxford Drug Design’s multi-level generative AI capability creates superior models to optimise molecular properties and thus …See details»
Oxford Drug Design | VentureRadar
Website: https://www.oxforddrugdesign.com/ Develops innovative drug discovery methods using cheminformatics databases and computer-aided compound design technology ...See details»
Oxford Drug Design – A new leader in AI-based drug discovery
We design and develop innovative therapeutics from pioneering Oxford science, with a unique and powerful combination of expertises that sets us apart.See details»
Oxford Drug Design Company Information - Funding, Investors
Track over 23,965 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 23,965 companies to help you find the right ones to partner with.See details»
Oxford Drug Design recieves over £8m in grant and equity …
Jun 18, 2019 According to the World Health Organization, an estimated 700,000 people die each year worldwide from bacterial infections. In the United States, an estimated 23,000 people die …See details»
Pipeline - Oxford Drug Design
In addition to our lead oncology program, we have two further programs in our pipeline with which we validated our distinctive platform. Using generous international non-dilutive funding from …See details»
Our Science - Oxford Drug Design
At Oxford Drug Design we leverage our knowledge of tRNA synthetases (aaRS) to rapidly advance multiple drug candidates to the clinic – promising new therapies designed to treat …See details»
Technology - Oxford Drug Design
In order to be useful, any AI drug discovery method must be based on a meaningful representation of chemical structure. A key differentiating strength of Oxford Drug Design is …See details»